Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Condition:  Malaria Interventions:  Biological: PfSPZ Vaccine;  Biological: PfSPZ Challenge (for CHMI);  Other: Normal Saline;  Biological: PfSPZ Challenge (for PfSPZ-CVac) Sponsors:  Sanaria Inc.;  Ifakara Health Institute;  Swiss Tropical & Public Health Institute;  Government of Equatorial Guinea;  Marathon Oil Corporation;  Noble Oil Services;  La Paz Medical Center, Malabo, Equatorial Guinea Not yet recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials